The Pharmacokinetics and Pharmacodynamics of Hemp-based Topical Cannabinoid Products
Status:
Recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the pharmacokinetic and pharmacodynamic effects of hemp-based
Cannabidiol (CBD) topical products (e.g., lotions, creams, patches) that contain low levels
of delta-9-tetrahydrocannabinol (THC).
Phase:
Phase 1
Details
Lead Sponsor:
Johns Hopkins University
Collaborator:
Substance Abuse and Mental Health Services Administration (SAMHSA)